Determining value and the contribution of ciclosporin-based therapies in dry eye disease: a European expert MCDA pilot study.
- DOI
- 10.33393/grhta.2026.3766
- Published
- 2026 Jan-Dec
- Container
- Global & regional health technology assessment
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.33393/grhta.2026.3766,
title = {Determining value and the contribution of ciclosporin-based therapies in dry eye disease: a European expert MCDA pilot study.},
author = {Ahmad S and Figueiredo F and Labetoulle M and Messmer EM and Schrader S and Steven P and Benítez-Del-Castillo JM},
year = {2026},
journal = {Global \& regional health technology assessment},
doi = {10.33393/grhta.2026.3766},
url = {https://doi.org/10.33393/grhta.2026.3766}
}RIS
TY - JOUR TI - Determining value and the contribution of ciclosporin-based therapies in dry eye disease: a European expert MCDA pilot study. AU - Ahmad S AU - Figueiredo F AU - Labetoulle M AU - Messmer EM AU - Schrader S AU - Steven P AU - Benítez-Del-Castillo JM PY - 2026 JO - Global & regional health technology assessment DO - 10.33393/grhta.2026.3766 UR - https://doi.org/10.33393/grhta.2026.3766 ER -
APA
S, A., F, F., M, L., EM, M., S, S., P, S., & JM, B. (2026). Determining value and the contribution of ciclosporin-based therapies in dry eye disease: a European expert MCDA pilot study.. Global & regional health technology assessment. https://doi.org/10.33393/grhta.2026.3766
Source records
- pubmed · retrieved 2026-11-10T10:51:31.603Z